Skip to main content
. 2022 Jan 5;13(1):1335–1345. doi: 10.1080/21655979.2021.2016088

Figure 5.

Figure 5.

HOXC10 facilitates BC development via IL6-JAK2/STAT3 pathway.

(a-d) Following HOXC10 overexpression and treatment with IL-6-neutralizing antibody in MCF7 and MDA-MB-231 cells, the proliferation, migration and invasion, and apoptosis rate was evaluated by CCK-8, transwell and TUNEL assays. *P < 0.05; **P < 0.01.